The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...
BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world's first CE-approved left bundle branch area pacing (LBBAP) high-voltage device. These next ...
What Is A Biventricular Pacemaker Or A CRT Device, How Is It Implanted, And Who Is A Good Candidate?
Dr. Hunter Champion answers the question: 'What Is A Biventricular Pacemaker?' — -- Question: What is a biventricular pacemaker or cardiac resynchronization therapy (also called a CRT device), ...
Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
WASHINGTON, DC—The vast majority of patients who develop an infection related to a cardiac implanted electronic device (CIED) do not have the hardware extracted in a timely manner, and these patients ...
Cardiac pacemaker implantation is a primary therapy for various arrhythmic disorders; however, safety concerns persist in India. This study aimed to evaluate two-year safety outcomes of cardiac ...
Please provide your email address to receive an email when new articles are posted on . The American College of Cardiology announced it has expanded the scope of a registry for electrophysiology ...
The heart is a finely tuned machine, pumping and squeezing to move blood through the body with a fresh supply of oxygen and nutrients. Electrical activity provides the spark to coordinate and activate ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Please provide your email address to receive an email when new articles are posted on . Major adverse events remained common in patients with nonischemic cardiomyopathy implanted with an electronic ...
The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results